pomalidomide has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomez, D; Li, Y; Liu, L; Palmisano, M; Reyes, J; Wang, X; Zhang, C; Zhou, S | 1 |
1 trial(s) available for pomalidomide and Liver Diseases
| Article | Year |
|---|---|
An Open-Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics.
Topics: Aged; Area Under Curve; Healthy Volunteers; Humans; Immunologic Factors; Liver; Liver Diseases; Male; Middle Aged; Severity of Illness Index; Thalidomide | 2019 |